NASDAQ · Medical - Devices

Anteris Technologies Global Corp. (AVR) Stock

$5.87 -2.17% NASDAQ: AVR Healthcare

Valuation

MetricValue
Price$5.87
Market Cap$572.08M
P/E Ratio-2.74
P/B Ratio2.92
P/S Ratio327.43
EPS (TTM)$-4.00
52-Week High$11.06
52-Week Low$3.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-77.66%
ROA-38.01%
ROCE-41.80%
Gross Margin-4700.00%
Operating Margin-4700.00%
Net Margin-51.49%
Debt/Equity0.01
Current Ratio0.76

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$3.0M$3.0M$3.0M$2.0M
Operating Profit$-17.0M$-31.0M$-48.0M$-78.0M$-94.0M
Net Profit$-17.0M$-31.0M$-46.0M$-76.0M$-94.0M
EPS$-0.48$-0.85$-1.28$-3.77$-2.55
Op Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$21.0M$16.0M$31.0M$81.0M$23.0M
Total Liabilities$11.0M$7.0M$12.0M$18.0M$23.0M
Cash$15.0M$9.0M$21.0M$70.0M$13.0M
Borrowings$4.0M$1.0M$2.0M$1.0M$2.0M

Latest News

Anteris Technologies Files Offering of Up to 5.39 Million Shares MT Newswires · Jul 1, 2026 TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge PR Newswire · Jun 15, 2026 France clearance marks key milestone for Anteris' pivotal PARADIGM Trial Proactive · Jun 8, 2026 Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis MT Newswires · Jun 8, 2026 Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance GlobeNewswire · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-29.0M$-35.0M$-61.0M$-78.0M
Investing Cash Flow$-1.0M$-3.0M$-5.0M$-5.0M$-3.0M
Financing Cash Flow$-1.0M$-1.0M$-3.0M$0$-1.0M
Net Cash Flow$12.0M$-6.0M$12.0M$49.0M$-58.0M
Free Cash Flow$-15.0M$-31.0M$-37.0M$-64.0M$-80.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.32
EV / EBITDA-4.77
FCF Yield-12.00%
Quick Ratio14.20
Interest Coverage-2042.96
Return 1Y148.18%
Return 3Y—
Return 5Y—

Ownership

Insiders Held16.47%
Institutions Held66.90%
Institutions Float Held80.09%
Institutional HolderSharesReport Date
L1 Capital Pty Ltd7,789,0002026-03-31
Nantahala Capital Management, LLC5,530,9102026-03-31
Sio Capital Management, LLC5,382,9652026-03-31
Blackrock Inc.4,889,1532026-03-31
Adar1 Capital Management, LLC 3,789,1322026-03-31

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is led by CEO Wayne Geoffrey Paterson, employs 136 people, headquartered in AU, publicly traded since 2024.

Anteris Technologies Global Corp. (AVR) stock trades at $5.87 with a market capitalization of $572.08M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.74, reflecting a net loss over the last twelve months, price-to-book of 2.92, price-to-sales of 327.43. Over the past 52 weeks the stock has ranged between $3.30 and $11.06, and currently trades 46.9% below its 52-week high.

On profitability, Anteris Technologies Global Corp. generates a return on equity (ROE) of -77.66% (negative, reflecting a net loss), return on capital employed of -41.80%, an operating margin of -4700.00%, a net profit margin of -51.49%.

Anteris Technologies Global Corp. by the numbers, 2020–2025

Between 2020 and 2025 Anteris Technologies Global Corp. reported revenue of $5.0M rising to $2.0M, a change of -60.0% across 6 years. Compounded, revenue has grown -16.7% a year over five years, -12.6% over three, -33.3% over the last twelve months. Net profit fell to $-94.0M.

Operating margin went from -243.0% in 2020 to -4908.2% in 2025, a fall of 4665.2 percentage points. The most recent net margin is -51.49%. On a trailing twelve-month basis to Jun '26, revenue is $1.0M and net profit $-103.0M.

Borrowings fell from $3.0M to $2.0M, cash from operations was $-78.0M in the latest year, positive in 0 of the last 6.

Return on equity has averaged -292.4% over five years, and was -120.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Anteris Technologies Global Corp. (AVR) — frequently asked questions

What is Anteris Technologies Global Corp. (AVR) stock price today?

Anteris Technologies Global Corp. (AVR) is currently trading at $5.87, down 2.17% today.

What is AVR P/E ratio?

Anteris Technologies Global Corp.'s P/E ratio is -2.74. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is AVR return on equity (ROE)?

Anteris Technologies Global Corp.'s return on equity (ROE) is -77.66%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Anteris Technologies Global Corp.'s market cap?

Anteris Technologies Global Corp. has a market capitalization of $572.08M.

Does AVR pay a dividend?

Anteris Technologies Global Corp. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does AVR carry?

Anteris Technologies Global Corp. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is AVR's profit margin?

Anteris Technologies Global Corp. reports a net profit margin of -51.49% — the share of revenue left after every cost, including tax and interest.

What sector is AVR in?

Anteris Technologies Global Corp. is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is AVR listed on?

Anteris Technologies Global Corp. trades on NASDAQ under the ticker AVR.

What is AVR's 52-week range?

Over the last year Anteris Technologies Global Corp. has traded between $3.30 and $11.06.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens AVR currently matches

On the figures above, Anteris Technologies Global Corp. passes the filters for 8 of our ready-made screens, among them Small Cap Stocks, Stocks Under $10, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksStocks Under $10Debt Free Stocks Under $100Debt Free StocksStocks Under $100Stocks Under $50Debt to Equity Below 1 StocksNegative Working Capital Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.